WORK MEDICAL TECHNOLOGY GR-A (WOK) Stock Fundamental Analysis

NASDAQ:WOK • KYG9767H1258

1.44 USD
-0.01 (-0.69%)
Last: Feb 20, 2026, 06:10 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

1

WOK gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 185 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of WOK have multiple concerns. WOK is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • WOK had negative earnings in the past year.
WOK Yearly Net Income VS EBIT VS OCF VS FCFWOK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 5M -5M -10M

1.2 Ratios

  • WOK has a Return On Assets (-10.67%) which is comparable to the rest of the industry.
  • WOK has a Return On Equity (-28.62%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -10.67%
ROE -28.62%
ROIC N/A
ROA(3y)-1.96%
ROA(5y)N/A
ROE(3y)-5.57%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
WOK Yearly ROA, ROE, ROICWOK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

  • Looking at the Gross Margin, with a value of 26.88%, WOK is doing worse than 78.38% of the companies in the same industry.
  • WOK's Gross Margin has improved in the last couple of years.
  • The Profit Margin and Operating Margin are not available for WOK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 26.88%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.79%
GM growth 5YN/A
WOK Yearly Profit, Operating, Gross MarginsWOK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 20 -20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. Health

2.1 Basic Checks

  • WOK does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • WOK has more shares outstanding than it did 1 year ago.
  • WOK has a worse debt/assets ratio than last year.
WOK Yearly Shares OutstandingWOK Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 500 1K
WOK Yearly Total Debt VS Total AssetsWOK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

  • Based on the Altman-Z score of 0.26, we must say that WOK is in the distress zone and has some risk of bankruptcy.
  • WOK has a Altman-Z score (0.26) which is in line with its industry peers.
  • WOK has a Debt/Equity ratio of 1.00. This is a neutral value indicating WOK is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 1.00, WOK is not doing good in the industry: 75.14% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1
Debt/FCF N/A
Altman-Z 0.26
ROIC/WACCN/A
WACC5.82%
WOK Yearly LT Debt VS Equity VS FCFWOK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 5M -5M 10M -10M

2.3 Liquidity

  • WOK has a Current Ratio of 1.14. This is a normal value and indicates that WOK is financially healthy and should not expect problems in meeting its short term obligations.
  • WOK has a Current ratio of 1.14. This is amonst the worse of the industry: WOK underperforms 84.32% of its industry peers.
  • A Quick Ratio of 0.98 indicates that WOK may have some problems paying its short term obligations.
  • WOK's Quick ratio of 0.98 is on the low side compared to the rest of the industry. WOK is outperformed by 76.22% of its industry peers.
Industry RankSector Rank
Current Ratio 1.14
Quick Ratio 0.98
WOK Yearly Current Assets VS Current LiabilitesWOK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • The earnings per share for WOK have decreased strongly by -278.50% in the last year.
  • Looking at the last year, WOK shows a quite strong growth in Revenue. The Revenue has grown by 8.89% in the last year.
  • Measured over the past years, WOK shows a very negative growth in Revenue. The Revenue has been decreasing by -36.93% on average per year.
EPS 1Y (TTM)-278.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-95.02%
Revenue 1Y (TTM)8.89%
Revenue growth 3Y-36.93%
Revenue growth 5YN/A
Sales Q2Q%-14.42%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
WOK Yearly Revenue VS EstimatesWOK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • WOK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
WOK Price Earnings VS Forward Price EarningsWOK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
WOK Per share dataWOK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -500 -1K -1.5K -2K -2.5K

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • WOK does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

WORK MEDICAL TECHNOLOGY GR-A

NASDAQ:WOK (2/20/2026, 6:10:34 PM)

1.44

-0.01 (-0.69%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)01-30
Earnings (Next)N/A
Inst Owners0.03%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2.48M
Revenue(TTM)10.74M
Net Income(TTM)-3.71M
AnalystsN/A
Price TargetN/A
Short Float %5.48%
Short Ratio0
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.23
P/FCF N/A
P/OCF N/A
P/B 0.19
P/tB 0.21
EV/EBITDA N/A
EPS(TTM)-2873.8
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS6.24
BVpS7.53
TBVpS6.96
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -10.67%
ROE -28.62%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 26.88%
FCFM N/A
ROA(3y)-1.96%
ROA(5y)N/A
ROE(3y)-5.57%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.79%
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity 1
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.14
Quick Ratio 0.98
Altman-Z 0.26
F-ScoreN/A
WACC5.82%
ROIC/WACCN/A
Cap/Depr(3y)251.52%
Cap/Depr(5y)N/A
Cap/Sales(3y)31.66%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-278.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-95.02%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)8.89%
Revenue growth 3Y-36.93%
Revenue growth 5YN/A
Sales Q2Q%-14.42%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-170.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-806.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-200.83%
OCF growth 3YN/A
OCF growth 5YN/A

WORK MEDICAL TECHNOLOGY GR-A / WOK FAQ

Can you provide the ChartMill fundamental rating for WORK MEDICAL TECHNOLOGY GR-A?

ChartMill assigns a fundamental rating of 1 / 10 to WOK.


Can you provide the valuation status for WORK MEDICAL TECHNOLOGY GR-A?

ChartMill assigns a valuation rating of 0 / 10 to WORK MEDICAL TECHNOLOGY GR-A (WOK). This can be considered as Overvalued.


How profitable is WORK MEDICAL TECHNOLOGY GR-A (WOK) stock?

WORK MEDICAL TECHNOLOGY GR-A (WOK) has a profitability rating of 1 / 10.


What is the financial health of WORK MEDICAL TECHNOLOGY GR-A (WOK) stock?

The financial health rating of WORK MEDICAL TECHNOLOGY GR-A (WOK) is 1 / 10.